|
Lisdexamfetamine Dimesylate - Dosage Concentration 70Mg, Pharmaceutical Form In Capsule, Capsule Presentation Form, Oral Administration Route, Losartan, Potassium - Concentration/Dosage 50 Mg, Tablet Pharmaceutical Form, Oral Administration Route, Ophthalmic Lubricant - ., ., Pharmaceutical Form Bottle, Eye Drops Optive Lubricant Or Substitute, Macrogol 3350 + Sodium Bicarbonate + Sodium Chloride + Potassium Chloride - Concentration/Dosage 13.125 G + 0.1775 G + 0.3507 G + 0.0466 G Respectively, Pharmaceutical Form Powder For Oral Solution, Presentation Form Sachet, Via Oral Administration, Mesalazine - Concentration/Dosage 400 Mg, Coated Tablet Pharmaceutical Form, Mesalazine - Concentration/Dosage 500 Mg, Pharmaceutical Form Suppository, Rectal Administration Route, Methylphenidate, Hydrochloride - Concentration/Dosage 18 Mg, Blister Or Strip, Hydrochloride - Concentration/Dosage 36 Mg, Pharmaceutical Form Extended Release Tablet, Hydrochloride - Concentration/Dosage 54 Mg, Pharmaceutical Form Extended Release Capsule, Blister, Hydrochloride - Concentration/Dosage 10 Mg, Hydrochloride - Concentration/Dosage 20 Mg, Pharmaceutical Form Capsule, Hydrochloride - Concentration/Dosage 30 Mg, Metoprolol, Tartrate - Concentration/Dosage 100 Mg, Coated Tablet, Packed In Blister Or Strip, Succinate - Concentration/Dosage 100 Mg, Pharmaceutical Form Controlled Release Coated Tablet, Succinate - Concentration/Dosage 25 Mg, Succinate - Concentration/Dosage 50 Mg, Form Blister Or Strip Presentation, Mycophenolate Mofetil - Concentration/Dosage 500 Mg, Mycophenolate Sodium - Concentration/Dosage 360 Mg, Gastroresistant Coated Tablet Pharmaceutical Form, Blister Presentation Form, Mirabegron - Mirabegron 50Mg, Coated Release Tablet Presentation, For Administration Oral, Mirtazapine - Concentration/Dosage 15 Mg, Coated Tablet Form, Montelukast Sodium - 10Mg, Oral, Mupirocin - Concentration/Dosage 20 Mg/G, Cream Pharmaceutical Form, Tube Presentation Form, Topical Route Of Administration, Nebivolol - Concentration/Dosage 5 Mg, Route Of Administration Oral, Nitrazepam - Concentration/Dosage 5 Mg, Octreotide - Octreotide Lar - Concentration/Dosage 0.1Mg/Ml, Pharmaceutical Form Powder For Injectable Suspension, Ampoule Vial Presentation Form. Packaging Containing 1 Ampoule Bottle Of 30 Mg + 1 Syringe Filled With 2.5 Ml Diluent + Application System Containing 02 Needles, Intramuscular Administration Route
|